AN-SULFUR COLLOID (technetium tc 99m sulfur colloid) by PharmaIN is 99m decays by isomeric transition, emitting a photon that can be detected for imaging purposes. First approved in 1978.
Drug data last refreshed 20h ago · AI intelligence enriched 1mo ago
AN-SULFUR COLLOID (Technetium Tc 99m Sulfur Colloid) is a radiopharmaceutical diagnostic agent approved in 1978 that uses radioactive decay to emit photons for medical imaging. It functions through uptake by the reticuloendothelial system or lymphatic transport depending on route of administration, enabling visualization of lymph nodes, shunts, esophageal transit, gastroesophageal reflux, and aspiration risk.
Product approaching loss of exclusivity signals potential team downsizing or portfolio realignment within the sponsor organization.
99m decays by isomeric transition, emitting a photon that can be detected for imaging purposes. Following subcutaneous injection, Technetium Tc 99m Sulfur Colloid enters the lymphatic capillaries and is transported with lymph to lymph nodes. However, when there is massive nodal metastatic…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Technetium Tc 99m Sulfur Colloid Injection for Tracing Sentinel Nodes in Breast Cancer
Worked on AN-SULFUR COLLOID at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on AN-SULFUR COLLOID offers stability in a niche diagnostic market but limited career growth due to mature product status and approaching loss of exclusivity. Roles focus on maintaining hospital relationships, ensuring compliance, and optimizing manufacturing rather than launching or expanding markets.